Carbamates are a class of chemical compounds widely used in pesticides and certain medications.
Unlike other biomarkers, such as cholesterol or blood glucose, carbamates do not have a direct, measurable presence in the human body. Instead, exposure to carbamates is typically assessed by measuring the metabolites of these compounds in biological samples, such as urine or blood.
Carbamates are organic compounds derived from carbamic acid, commonly used in pesticides (insecticides, herbicides, and fungicides) and medications. Examples include insecticides and herbicides like carbaryl, methomyl, aldicarb, and medications like meprobamate, and rivastigmine.
Carbamate-based medications are used to treat various conditions including hepatitis C, epilepsy, HIV, and Alzheimer’s disease.
These compounds inhibit acetylcholinesterase, an enzyme essential for nerve function, leading to overstimulation of the nervous system.
While carbamates are valuable in medicine for their ability to enhance drug stability, bioavailability, and pharmacokinetics, they can also cause toxicity, especially from pesticide exposure.
Symptoms of carbamate poisoning resemble organophosphate toxicity and include excessive salivation, respiratory difficulties, and neurological effects, requiring prompt treatment for recovery.
Symptoms of carbamate toxicity include:
Human exposure to environmental carbamates generally occurs through three main routes:
Carbamate toxicity from medications is less common than toxicity from insecticides and pesticides.
Medications such as rivastigmine (used for Alzheimer's disease) and neostigmine (used for myasthenia gravis) can cause overdose when these drugs inhibit acetylcholinesterase, leading to an accumulation of acetylcholine and overstimulation of the nervous system.
While symptoms resemble those of pesticide exposure, they are typically less severe due to controlled dosing.
Treatment focuses on reducing acetylcholine activity with atropine and ensuring respiratory support. Recovery from this usually occurs more quickly than from pesticide toxicity.
Carbamates are rapidly metabolized by the liver in the human body, and measuring the parent compounds directly in biological samples is challenging. Instead, clinicians assess exposure by testing for metabolites, the breakdown products of carbamates, which are easier to detect and provide a clearer picture of exposure.
Metabolites such as alpha-naphthol from carbaryl, isopropoxyphenol from propoxur, and carbofuran phenol from carbofuran are excreted in urine.
Urine is the most common sample for testing because metabolites are typically excreted in urine after exposure. Blood can also be tested in certain cases, but urine samples tend to show higher concentrations of metabolites.
Testing for carbamate exposure is relevant in several clinical situations:
Testing for carbamate exposure is generally recommended within 48 hours of exposure.
Testing involves collecting biological samples, typically urine, soon after suspected exposure. Blood samples may also be used, especially if testing for the parent compound is of interest.
This is critical because carbamate metabolites are excreted relatively quickly. In the laboratory, techniques like High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) are often used to quantify and identify metabolites accurately.
The timing of sample collection is very important; testing too long after exposure may result in low or undetectable levels of metabolites, leading to false negatives. Ensuring that testing is conducted within the appropriate time frame after exposure is vital for accurate results.
The presence of carbamate metabolites in biological samples confirms that an individual has been exposed to carbamates. However, interpreting these results requires context:
Elevated metabolite levels generally indicate recent exposure. The concentration of metabolites can offer a rough estimate of exposure level, but it is important to consider factors like the time since exposure and individual metabolic differences.
Low or undetectable levels may suggest no recent exposure or that the exposure was below the detection limit. However, due to the rapid metabolism of carbamates, metabolites may no longer be detectable long after the exposure has occurred.
Test results must always be interpreted in conjunction with the patient’s clinical symptoms and exposure history. For example, a person may have been exposed to carbamates in the past, but the metabolites may not be detectable at the time of testing due to the timing of the sample collection.
Click here to compare testing options and order tests to assess for environmental toxin exposure.
Bradman, A., & Whyatt, R. M. (2005). Characterizing exposures to nonpersistent pesticides during pregnancy and early childhood in the National Children's Study: a review of monitoring and measurement methodologies. Environmental health perspectives, 113(8), 1092–1099. https://doi.org/10.1289/ehp.7769
Delaware Health and Social Services. 24/7 Emergency Contact Number: 1-888-295-5156 CARBAMATE INSECTICIDES. (n.d.). https://dhss.delaware.gov/DHSS/DPH/files/carbamfaq.pdf
Matošević, A., & Bosak, A. (2020). Carbamate group as structural motif in drugs: a review of carbamate derivatives used as therapeutic agents. Arhiv za higijenu rada i toksikologiju, 71(4), 285–299. https://doi.org/10.2478/aiht-2020-71-3466
N-Methyl Carbamate Insecticides Toxicology. (n.d.). https://www.epa.gov/sites/default/files/documents/rmpp_6thed_ch6_carbamates.pdf
Silberman J, Taylor A. Carbamate Toxicity. [Updated 2023 May 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482183/
UpToDate. (2019). Uptodate.com. https://www.uptodate.com/contents/organophosphate-and-carbamate-poisoning